Racial/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users

Drug and Alcohol Dependence

Volumn 151, Issue , 2015, Pages 278-283

  Martins, Silvia S ^a   Santaella Tenorio, Julian ^a   Marshall, Brandon D L ^b   Maldonado, Adriana ^a   Cerdá, Magdalena ^a  

^a Columbia University ^*  (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Heroin; Heroin risk behaviors; National Survey on Drug Use and Health; Nonmedical use of prescription opioids; Race ethnicity

Indexed keywords

DIAMORPHINE; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; CAUCASIAN; CHILD; CONTROLLED STUDY; ETHNICITY; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HISPANIC; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; UNITED STATES; AGE; AMERICAN INDIAN; BLACK PERSON; COMPLICATION; DRUG MISUSE; ETHNIC GROUP; FEMALE; MALE; PSYCHOLOGY; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; ANALGESICS, OPIOID; CHILD; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEROIN DEPENDENCE; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; MALE; PRESCRIPTION DRUG MISUSE; RISK-TAKING; SEX FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84929959301     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.03.020     Document Type: Article

References (42)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, APA, Washington, DC.
2. Becker W.C., Sullivan L.E., Tetrault J.M., Desai R.A., Fiellin D.A. Non-medical use, abuse and dependence on prescription opioids among US adults: psychiatric, medical and substance use correlates. Drug Acohol Depend. 2008, 94:38-47.
3. Bernstein E., Bernstein J., Tassiopoulos K., Valentine A., Heeren T., Levenson S., Hingson R. Racial and ethnic diversity among a heroin and cocaine using population: treatment system utilization. J. Addict. Dis. 2006, 24:43-63.
4. Bernstein J., Bernstein E., Shepard D.S., Valentine A., Heeren T., Winter M., Levenson S., Beaston-Blaakman A., Tassiopoulos K., Hingson R. Racial and ethnic differences in health and health care: lessons from an inner-city patient population actively using heroin and cocaine. J. Ethn. Subst. Abuse 2006, 5:35-50.
5. Blanco C., Alderson D., Ogburn E., Grant B.F., Nunes E.V., Hatzenbuehler M.L., Hasin D.S. Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug Alcohol Depend. 2007, 90:252-260.
6. Brands B., Blake J., Sproule B., Gourlay D., Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004, 73:199-207.
7. Cerdá, M., Santaella, J., Marshall, B., Kim, J., Martins, S., under review. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study. J. Pediatr.
8. Chromy J., Abeyasekera S. Statistical analysis of survey data. Household Sample Surveys in Developing and Transition Countries Studies in Methods Department of Economic and Social Affairs Statistics Division 2005, United Nations, New York, NY. United Nations (Ed.).
9. Ciccarone D., Unick G.J., Kraus A. Impact of South American heroin on the US heroin market 1993-2004. Int. J. Drug Policy 2009, 20:392-401.
10. Cicero T.J., Ellis M.S., Surratt H.L. Effect of abuse-deterrent formulation of OxyContin. N. Engl. J. Med. 2012, 367:187-189.
11. Cicero T.J., Ellis M.S., Surratt H.L., Kurtz S.P. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry 2014, 71:821-826.
12. ® and other opioid analgesics in the United States: 2002-2004. J. Pain 2005, 6:662-672.
13. Cleland C.M., Rosenblum A., Fong C., Maxwell C. Age differences in heroin and prescription opioid abuse among enrolees into opioid treatment programs. Subst. Abuse Treat. Prev. Policy 2011, 6:11.
14. Compton W.M., Volkow N.D. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006, 83:S4-S7.
15. Fischer B., Bibby M., Bouchard M. The global diversion of pharmaceutical drugs non-medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures. Addiction 2010, 105:2062-2070.
16. Golub A., Johnson B.D. The new heroin users among Manhattan arrestees: variations by race/ethnicity and mode of consumption. J. Psychoact. Drugs 2005, 37:51-61.
17. Green C.R., Ndao-Brumblay S.K., West B., Washington T. Differences in prescription opioid analgesic availability: comparing minority and white pharmacies across Michigan. J. Pain 2005, 6:689-699.
18. Jones C.M. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013, 132:95-100.
19. Keyes K.M., Cerda M., Brady J.E., Havens J.R., Galea S. Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. Am. J. Public Health 2013, 104:e52-e59.
20. Drug Use Among Racial/Ethnic Minorities 1998, DIANE Publishing Company, New York, NY. A.N. Kopstein (Ed.).
21. Lankenau S.E., Teti M., Silva K., Bloom J.J., Harocopos A., Treese M. Initiation into prescription opioid misuse amongst young injection drug users. Int. J. Drug Policy 2012, 23:37-44.
22. Lankenau S.E., Teti M., Silva K., Bloom J.J., Harocopos A., Treese M. Patterns of prescription drug misuse among young injection drug users. J. Urban Health 2012, 89:1004-1016.
23. Mack K.A. Drug-induced deaths-United States, 1999-2010. MMWR Surveill. Summ. 2013, 161.
24. Manchikanti L. National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician 2007, 10:399-424.
25. Mars S.G., Bourgois P., Karandinos G., Montero F., Ciccarone D. Every 'Never' I ever said came true: transitions from opioid pills to heroin injecting. Int. J. Drug Policy 2013, 25:257-266.
26. McCabe S.E., Morales M., Cranford J.A., Delva J., McPherson M.D., Boyd C.J. Race/ethnicity and gender differences in drug use and abuse among college students. J. Ethn. Subst. Abuse 2007, 6:75-95.
27. Miller C.L., Wood E., Spittal P.M., Li K., Frankish J.C., Braitstein P., Montaner J.S., Schechter M.T. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. J. Acquir. Immune Defic. Syndr. 2004, 36:743-749.
28. Morral A.R., McCaffrey D.F., Chien S. Measurement of adolescent drug use. J. Psychoact. Drugs 2003, 35:301-309.
29. Morrison R.S., Wallenstein S., Natale D.K., Senzel R.S., Huang L.-L. We don't carry that-failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N. Engl. J. Med. 2000, 342:1023-1026.
30. Paulozzi L. Populations at Risk for Opioid Overdose. Center for Disease Control 2012, US Food and Drug Administration, Washington, DC.
31. Paulozzi L.J. Drug-induced deaths - United States, 2003-2007. MMWR Surveill Summ. 2011, 60 (Suppl.):60-61. CCD.
32. Pletcher M.J., Kertesz S.G., Kohn M.A., Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA 2008, 299:70-78.
33. Rudd R., Paulozzi L., Bauer M., Burleson R., Carlson R., Dao D., Davis J., Dudek J., Eichler B., Fernandes J., Fondario A., Gabella B., Hume B., Huntamer T., Kariisa M., Largo T., Miles J., Newmyer A., Nitcheva D., Perez B., Proescholdbell S., Sabel J., Skiba J., Slavova S., Stone K., Tharp J., Wendling T., Wright D., Zehner A. Increases in heroin overdose deaths-28 states, 2010 to 2012. MMWR 2014, 63:849-854.
34. SAMHSA Results from the 2008 National Survey on Drug Use and Health: National Findings. NSDUH Series H-36, HHS Publication No. SMA 09-4434 2009, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD.
35. SAMHSA Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publication No. SMA 11-4658 2011, Substance Abuse and Mental Health Services Administration, Rockville, MD.
36. SAMHSA Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-44, HHS Publication No. (SMA) 12-4713 2012, Substance Abuse and Mental Health Services Administration, Rockville, MD.
37. SAMHSA Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-46, HHS Publication No. SMA 13-4795 2013, Substance Abuse and Mental Health Services Administration, Rockville, MD.
38. STATA StataCorp. Stata Statistical Software: Release 13 2013, StataCorp LP, College Station, TX.
39. Thorpe L.E., Ouellet L.J., Hershow R., Bailey S.L., Williams I.T., Williamson J., Monterroso E.R., Garfein R.S. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am. J. Epidemiol. 2002, 155:645-653.
40. Unick G.J., Rosenblum D., Mars S., Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PloS ONE 2013, 8:e54496.
41. Volkow N.D., McLellan T.A., Cotto J.H., Karithanom M., Weiss S.R. Characteristics of opioid prescriptions in 2009. JAMA 2011, 305:1299-1301.
42. Young A.M., Havens J.R. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction 2012, 107:587-596.